OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The clinical progress and challenges of mRNA vaccines
Meng‐Zhen Yu, Nannan Wang, Jiaqing Zhu, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2023) Vol. 15, Iss. 5
Closed Access | Times Cited: 10

Showing 10 citing articles:

mRNA vaccines in the context of cancer treatment: from concept to application
Qiang Fu, Xiaoming Zhao, Jinxia Hu, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1

mRNA vaccine platforms: linking infectious disease prevention and cancer immunotherapy
Dariush Haghmorad, Majid Eslami, Niloufar Orooji, et al.
Frontiers in Bioengineering and Biotechnology (2025) Vol. 13
Open Access

Leveraging high-throughput screening technologies in targeted mRNA delivery
Yuchen Zhang, Zhifei Gao, Xiao Yang, et al.
Materials Today Bio (2024) Vol. 26, pp. 101101-101101
Open Access | Times Cited: 4

mRNA-based vaccines – global approach, challenges, and could be a promising wayout for future pandemics
Shivani Makhijani, Gehan M. Elossaily, Satish Rojekar, et al.
Pharmaceutical Development and Technology (2024) Vol. 29, Iss. 6, pp. 559-565
Closed Access | Times Cited: 4

Nanotechnology-based drug delivery strategies for cancer therapy
Yinsheng Xu, Xiangyu Ren, Mengzhen Yu, et al.
Chinese Science Bulletin (Chinese Version) (2023) Vol. 68, Iss. 32, pp. 4346-4372
Closed Access | Times Cited: 7

mRNA vaccine in gastrointestinal tumors: Immunomodulatory effects and immunotherapy
Ao Zhang, Qingming Ji, Xia Sheng, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115361-115361
Open Access | Times Cited: 6

The potential of N2-modified cap analogues for precise genetic manipulation through mRNA engineering
Karol Kurpiejewski, Anna Stankiewicz-Drogoń, Karolina Piecyk, et al.
Frontiers in Molecular Biosciences (2024) Vol. 10
Open Access | Times Cited: 1

Innovative Strategies to Enhance mRNA Vaccine Delivery and Effectiveness: Mechanisms and Future Outlook
Abhishek Verma, Ankit Awasthi
Current Pharmaceutical Design (2024) Vol. 30, Iss. 14, pp. 1049-1059
Closed Access | Times Cited: 1

RNA-based nanomedicines and their clinical applications
Lin-Jia Su, Z. Ji, Mo-Xi Xu, et al.
Nano Research (2023) Vol. 16, Iss. 12, pp. 13182-13204
Closed Access | Times Cited: 3

The Potential of mRNA Vaccines to Fight Against Viruses
Xinyi Wang
Viral Immunology (2024) Vol. 37, Iss. 8, pp. 383-391
Closed Access

Innovative Dual mRNA-Lipid Nanoparticle Therapy Targeting CRHBP and CFHR3 for Enhanced Treatment of Hepatocellular Carcinoma
Tianmei Fu, Boxuan Zhou, Yingliang Li, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 13183-13199
Open Access

Page 1

Scroll to top